Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Halozyme Temporarily Halts Phase II Trial For Pancreatic Cancer Treatment

April 4, 2014 8:27 am | News | Comments

Halozyme Therapeutics has announced that as a result of a recommendation received yesterday from an independent Data Monitoring Committee (DMC),  it is temporarily halting patient enrollment and dosing of PEGPH20 in an ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer.

TOPICS:

Texas Officials Offer Little Evidence of Threats to Execution Drugmakers

April 4, 2014 8:16 am | by BAILEY ELISE McBRIDE, Associated Press; NOMAAN MERCHANT, Associated Press | News | Comments

Texas prison officials have offered scant evidence to support their claim that pharmacies that supply the state with execution drugs would be in danger of violence if their identities were made public.        

TOPICS:

House GOP Moves Against Health Care Law

April 4, 2014 8:11 am | by ERICA WERNER, Associated Press | News | Comments

House Republicans renewed their election-year assault on President Barack Obama's health care law Thursday, their opposition undimmed just days after Obama celebrated news that more than 7 million Americans had signed up for coverage under the law.

TOPICS:
Advertisement

Three Meningitis Deaths Reported in Los Angeles County

April 4, 2014 8:06 am | News | Comments

Three of eight people who contracted bacterial meningitis this year have died, and all three had sex with other men, Los Angeles County health officials said.                

TOPICS:

Health Insurance Isn't a Year-Round Thing Anymore

April 4, 2014 8:03 am | by CONNIE CASS, Associated Press | News | Comments

Here's more fallout from the health care law: Until now, customers could walk into an insurance office or go online to buy standard health care coverage any time of year. Not anymore.           

TOPICS:

Arkansas to Ask Court to Reconsider Drug Fine

April 3, 2014 6:29 pm | by Andrew Demillo - Associated Press - Associated Press | News | Comments

Arkansas Attorney General Dustin McDaniel said Thursday he plans to ask the state Supreme Court to reconsider its decision tossing out a $1.2 billion judgment against drugmaker Johnson & Johnson over the marketing of the antipsychotic drug Risperdal.

TOPICS:

Maine Supreme Court Upholds HoltraChem Cleanup

April 3, 2014 3:31 pm | News | Comments

A pharmaceutical company must complete the cleanup of the former HoltraChem Manufacturing Co. plant in Orrington, Maine's highest court said Thursday.                 

TOPICS:

Stay Granted for New Arizona Abortion-Drug Rules

April 3, 2014 3:17 pm | by ASTRID GALVAN, Associated Press | News | Comments

The nation's most stringent restrictions on the use of abortion drugs are now temporarily on hold one day after going into effect in Arizona. A federal appeals court has granted a temporary stay on new regulations that took effect Tuesday. The ruling came in response to an appeal by Planned Parenthood Arizona and other groups after a federal judge in Tucson refused to temporarily block the rules.

TOPICS:
Advertisement

Supreme Court to Decide Texas Execution Drug Case

April 3, 2014 3:12 pm | by MICHAEL GRACZYK, Associated Press | News | Comments

Attorneys for a serial killer asked the U.S. Supreme Court to halt his execution set for Thursday in Texas as they challenge that state's refusal to release information about where it gets its lethal injection drug.      

TOPICS:

Ex-Virginia Attorneys General: Drop McDonnell's Charges

April 3, 2014 3:04 pm | by LARRY O'DELL, Associated Press | News | Comments

Five former Virginia attorneys general have asked a federal judge to consider their argument that public corruption charges against ex-Gov. Bob McDonnell should be dismissed. The former Republican governor and his wife Maureen are charged in a 14-count indictment with accepting more than $165,000 from Jonnie Williams, the former CEO of dietary supplements maker Star Scientific in exchange for helping promote his products.

TOPICS:

Matcon Relocates USA Operation to Elmhurst, IL

April 3, 2014 11:26 am | News | Comments

Matcon Group Limited announced today the relocation of its USA Operation from Sewell, New Jersey to Elmhurst, Illinois.  The Elmhurst facility is home to The Fitzpatrick Company.  Both Matcon and Fitzpatrick are companies within the IDEX Material Processing Technologies (MPT) Platform; the combined location will form an IDEX MPT Center of Excellence.

TOPICS:

FDA Approves EVZIO for the Emergency Treatment of Opioid Overdose

April 3, 2014 11:01 am | News | Comments

Kaleo announced that the FDA has approved EVZIO (naloxone hydrochloride injection) for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.      

TOPICS:

$1,000-a-Day Hepatitis C Drug Is a Blockbuster

April 3, 2014 8:56 am | Videos | Comments

Runaway demand for a life-saving hepatitis C treatment that costs $1,000 a day could send insurers' earnings per share down by double-digit percentages this year.               

TOPICS:

Writing to Escape a Strange Disease

April 3, 2014 8:44 am | Videos | Comments

Schuyler Ebersol turned to writing to help overcome a strange disease.                              

TOPICS:

NYC Doctor on Trial in Patients' Overdose Deaths

April 3, 2014 8:33 am | by JENNIFER PELTZ, Associated Press | News | Comments

The manslaughter case — believed to be the first in New York against a doctor in an overdose death — illustrates the growing reach of criminal prosecutions against physicians amid concerns about prescription drug abuse.     

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading